Helping research labs store, manage, and visualise data

Drug discovery is complex. But your software does not have to be.

We make easy-to-use software available to scientists and projects managers working on pre-clinical drug discovery.

Use grit Scientific Data Management to collect, align, store, and manage research data from multiple sources.
Use gritAnimal to plan and report on animal studies and get an easy overview of stable capacity.

We made it our mission to understand what you do

We think software must be user-friendly and intuitive to become successful.

So we made it our mission to exactly understand the work that you do. We have done this continually through 15 years of anthropological observations in labs focused on pre-clinical drug discovery.

Reducing workflows from days to minutes

In other words, we have been observing domain experts for years, and subsequently designed the ideal software to support them.

Our insights from all these observations, ultimately resulted in experiment centric software, enabling workflows to be reduced from days to minutes – all while being user-friendly, intuitive, and supporting what you’re already doing.

We call it scientific software for humans

Scientific software for humans – made by humans. And Marvin.

We hate software that’s overly complex because no one bothered to actually understand the domain they’re in. So if you’re tired of broken workflows in your software and headaches from endless import – export, we might be your new best friend.

We are going open source

Our main product, the grit Scientific Data Management Platform, is about to change.

We decided to stop selling the platform on a traditional software license and instead offer it free of charge as open source under a GPL license.

Read why and what it means here

Upcoming grit42 modules and products (1)

In the words of...

Words of wisdom shared by our esteemed customers, brilliant collaborators, and valued partners.

grit42 and Zealand Pharma have, for many years, collaborated to effectively report Zealand Pharma’s animal use to the authorities.

Recently, we have been able to further increase our efficiency with the addition of a new overview module that has simplified our ability to track how many rodents we have in our facilities and to plan future study capacity.”

Bill Vestergaard

Principal Scientist, Zealand Pharma

grit42 has given our project team access to enterprise level software tools for data management, archiving and analysis which are uniquely able to work with discovery, clinical and clinical data sets in an interoperable environment.

They are a great company and we are very proud to collaborate with them to try and improve the process of antibiotic drug discovery through the implementation of FAIR data management and tools.

Philip Gribbon

Head of Discovery Research at Fraunhofer ITMP

grit42 is providing the IMI ERA4TB project with innovative, flexible data management solutions that greatly facilitate the handling of the variety of complex drug discovery and development datasets needed to support world-class TB research.

Carlos Diaz

Founder & CEO, Synapse Research Management

Based on our experience and the ability to organize all data types in a consistent fashion, this platform can be a key tool for any researcher to address key scientific questions within the areas of drug development and translational research activities.

Patrick O'Meara

Data Team Manager, C-Path

As our research in Nucleic acid-based medicine involves data generation from biological and in silico experiments, both from several different sources, it is of utmost importance that our data consolidation process is streamlined and that the stored data is easily accessible, which is what we get with grit42.

Søren Rasmussen

Director Neuroscience Discovery, Contera Pharma

We see a great potential in applying state-of-the-art data management and data integration to leverage our R&D activities and improve our decision making. To strengthen these capabilities, we selected grit42 as our strategic software partner.

Thorsten Thormann

VP of Research, LEO Pharma

For identification of phenotypes of mutants, we use the high-throughput phenotypic microarrays from OmniLog®. The Growth Curves app from grit42 offers a nice and interactive way to analyse this data as well as making our analysis workflow 15 times faster!

Michael Mourez

Bacterial Infections Group Head at EVOTEC